Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North American Nicotine is a leading supplier of high-purity, USP-grade nicotine and nicotine salts for the pharmaceutical, nutraceutical, and electronic nicotine delivery systems (ENDS) industries. The company specializes in the extraction and purification of nicotine to meet stringent regulatory standards, including USP and EP specifications. Their product portfolio includes liquid nicotine, nicotine salts such as nicotine salicylate and nicotine benzoate, and customized solutions for nicotine replacement therapies (NRT). Based in the United States, they focus on providing consistent, high-quality ingredients for smoking cessation products and medical research applications. The company operates with a focus on compliance and quality control to support manufacturers in highly regulated global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North America Nicotine.